Table 2.
Treatment groups evaluated in the canine lateral ridge defects
| Treatment Group | Particle diameter µm |
rhBMP-2 µg cm−3 defect volume |
n 16 weeks |
|---|---|---|---|
| ACS | N/A | 400 | 6 |
| CR | 100 – 500 | 0 | 6 |
| CR-L | 100 – 500 | 200 | 6 |
| CR-H | 100 – 500 | 400 | 6 |
Treatment groups evaluated in the canine lateral ridge defects
| Treatment Group | Particle diameter µm |
rhBMP-2 µg cm−3 defect volume |
n 16 weeks |
|---|---|---|---|
| ACS | N/A | 400 | 6 |
| CR | 100 – 500 | 0 | 6 |
| CR-L | 100 – 500 | 200 | 6 |
| CR-H | 100 – 500 | 400 | 6 |